Improved systems for hydrophobic tagging of recombinant immunogens for efficient iscom incorporationANDERSSON, C; SANDBERG, L; WERNERUS, H et al.Journal of immunological methods. 2000, Vol 238, Num 1-2, pp 181-193, issn 0022-1759Article

Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscomsLARSSON, M; LÖVGREN, K; MOREIN, B et al.Journal of immunological methods. 1993, Vol 162, Num 2, pp 257-260, issn 0022-1759Article

Effect of priming on subsequent response to inactivated influenza vaccinePOTTER, C. W; JENNINGS, R.Vaccine. 2003, Vol 21, Num 9-10, pp 940-945, issn 0264-410X, 6 p.Conference Paper

Iscom, a delivery system for parenteral and mucosal vaccinationMOREIN, B; VILLACRES-ERIKSSON, M; LÖVGREN-BENGTSSON, K et al.Developments in biological standardization. 1998, Num 92, pp 33-39, issn 0301-5149Conference Paper

Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrixRÖNNBERG, B; MAKONNEN FEKADU; MOREIN, B et al.Vaccine. 1995, Vol 13, Num 14, pp 1375-1382, issn 0264-410XArticle

Immune responses to ISCOM® formulations in animal and primate modelsSJÖLANDER, Anders; DRANE, Debbie; MARASKOVSKY, Eugene et al.Vaccine. 2001, Vol 19, Num 17-19, pp 2661-2665, issn 0264-410XConference Paper

Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosisDA FONSECA, D. P. A. J; FRERICHS, J; SINGH, M et al.Vaccine. 2000, Vol 19, Num 1, pp 122-131, issn 0264-410XArticle

Adjuvant activity of iscoms ; effect of ratio and co-incorporation of antigen and adjuvantBENGTSSON, K. L; SJÖLANDER, A.Vaccine. 1996, Vol 14, Num 8, pp 753-760, issn 0264-410XArticle

Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscomsBEHBOUDI, S; MOREIN, B; RÖNNBERG, B et al.Vaccine. 1995, Vol 13, Num 17, pp 1690-1696, issn 0264-410XArticle

Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccineCOULTER, Alan; HARRIS, Rodney; DAVIS, Roslyn et al.Vaccine. 2003, Vol 21, Num 9-10, pp 946-949, issn 0264-410X, 4 p.Conference Paper

Induction of virus-specific immunity by iscomsOSTERHAUS, A. D. M. E; RIMMELZWAAN, G. F.Developments in biological standardization. 1998, Num 92, pp 49-58, issn 0301-5149Conference Paper

Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensisGOLOVLIOV, I; ERICSSON, M; AKERBLOM, L et al.Vaccine. 1995, Vol 13, Num 3, pp 261-267, issn 0264-410XArticle

Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccinesMUMFORD, J. A; JESSETT, D; DUNLEAVY, U et al.Vaccine. 1994, Vol 12, Num 9, pp 857-863, issn 0264-410XArticle

Protective immune response to 16 kDa immunoreactive Recombinant protein encoding the C-terminal VP1 portion of Foot and Mouth Disease Virus type Asia 1BAYRY, J; PRABHUDAS, K; GOPALAKRISHNA, S et al.Microbiology and immunology. 1999, Vol 43, Num 8, pp 765-771, issn 0385-5600Article

Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infectionHUISMAN, W; KARLAS, J. A; SIEBELINK, K. H. J et al.Vaccine. 1998, Vol 16, Num 2-3, pp 181-187, issn 0264-410XArticle

Studies on experimental adjuvanted influenza vaccines : Comparison of immune stimulating complexes (Iscoms^TM) and oil-in-water vaccinesCOULTER, A; WONG, T.-Y; DRANE, D et al.Vaccine. 1998, Vol 16, Num 11-12, pp 1243-1253, issn 0264-410XArticle

In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoidsBEHBOUDI, S; MOREIN, B; VILLACRES-ERIKSSON, M et al.Clinical and experimental immunology (Print). 1996, Vol 105, Num 1, pp 26-30, issn 0009-9104Article

Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production exposure to immunostimulating complexesVILLACRES-ERIKSSON, M.Clinical and experimental immunology (Print). 1995, Vol 102, Num 1, pp 46-52, issn 0009-9104Article

Delivery of pseudorabies virus envelope antigens enclosed in immunostimulating complexes (ISCOMs) : elicitation of neutralizing antibody and lymphoproliferative responses in swine and protection in miceTULMAN, E. R; GARMENDIA, A. E.Vaccine. 1994, Vol 12, Num 14, pp 1349-1354, issn 0264-410XArticle

Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human useDELIYANNIS, G; JACKSON, D. C; DYER, W et al.Vaccine. 1998, Vol 16, Num 20, pp 2058-2068, issn 0264-410XArticle

Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunizationHSU, S.-C; SCHADECK, E. B; DELMAS, A et al.Vaccine. 1996, Vol 14, Num 12, pp 1159-1166, issn 0264-410XArticle

Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in miceGHAZI, H. O; ERTURK, M; STANNARD, L. M et al.Archives of virology. 1995, Vol 140, Num 6, pp 1015-1031, issn 0304-8608Article

Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a productionFERNANDO, G. J. P; STENZEL, D. J; TINDLE, R. W et al.Vaccine. 1995, Vol 13, Num 15, pp 1460-1467, issn 0264-410XArticle

Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccineRIMMELZWAAN, G. F; BAARS, M; VAN BEEK, R et al.Vaccine. 1999, Vol 17, Num 20-21, pp 2512-2516, issn 0264-410XArticle

Page / 3